Bayer AG PK Valuation
| BAYRYDelisted Stock | USD 16.86 0.86 5.37% |
At this time, the firm appears to be overvalued. Bayer AG PK shows a prevailing Real Value of $13.47 per share. The current price of the firm is $16.86. Our model approximates the value of Bayer AG PK from analyzing the firm fundamentals such as Current Valuation of 87.41 B, profit margin of 0.09 %, and Return On Equity of 0.13 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Bayer AG's price fluctuation is very steady at this time. Calculation of the real value of Bayer AG PK is based on 3 months time horizon. Increasing Bayer AG's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Bayer AG is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Bayer Pink Sheet. However, Bayer AG's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 16.86 | Real 13.47 | Hype 16.86 | Naive 17.07 |
The intrinsic value of Bayer AG's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Bayer AG's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Bayer AG PK helps investors to forecast how Bayer pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Bayer AG more accurately as focusing exclusively on Bayer AG's fundamentals will not take into account other important factors: Bayer AG Total Value Analysis
Bayer AG PK is currently projected to have takeover price of 87.41 B with market capitalization of 64.01 B, debt of 35.55 B, and cash on hands of 9.07 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Bayer AG fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
87.41 B | 64.01 B | 35.55 B | 9.07 B |
Bayer AG Investor Information
The company has price-to-book (P/B) ratio of 1.36. Some equities with similar Price to Book (P/B) outperform the market in the long run. Bayer AG PK has Price/Earnings To Growth (PEG) ratio of 1.31. The entity last dividend was issued on the 2nd of May 2022. The firm had 4:1 split on the 20th of September 2017. Bayer AG PK is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Bayer AG Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Bayer AG has an asset utilization ratio of 36.66 percent. This suggests that the Company is making $0.37 for each dollar of assets. An increasing asset utilization means that Bayer AG PK is more efficient with each dollar of assets it utilizes for everyday operations.Bayer AG Ownership Allocation
Bayer AG holds a total of 3.93 Billion outstanding shares. Almost 99.9 percent of Bayer AG outstanding shares are held by general public with 0.1 % by other corporate entities. On September 18, 2024, Representative Michael McCaul of US Congress acquired $15k to $50k worth of Bayer AG PK's common stock.Bayer AG Profitability Analysis
The company reported the revenue of 44.08 B. Net Income was 1000 M with profit before overhead, payroll, taxes, and interest of 27.04 B.About Bayer AG Valuation
Our relative valuation model uses a comparative analysis of Bayer AG. We calculate exposure to Bayer AG's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Bayer AG's related companies.Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany. Bayer Aktienges is traded on OTC Exchange in the United States.
8 Steps to conduct Bayer AG's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Bayer AG's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Bayer AG's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Bayer AG's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Bayer AG's revenue streams: Identify Bayer AG's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Bayer AG's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Bayer AG's growth potential: Evaluate Bayer AG's management, business model, and growth potential.
- Determine Bayer AG's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Bayer AG's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Bayer AG Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 982.4 M | |
| Quarterly Earnings Growth Y O Y | 5.424 | |
| Forward Price Earnings | 6.5833 | |
| Retained Earnings | 13.3 B |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Consideration for investing in Bayer Pink Sheet
If you are still planning to invest in Bayer AG PK check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bayer AG's history and understand the potential risks before investing.
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |